Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Macaluso

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Urological Research|February 7, 2002
The genetic alterations in the oncogenic pathway of transitional cell carcinoma of the bladder and its prognostic valueP Gontero, A Tizzani, G H Muir, et al.
European Urology|January 1, 1996
Marker tumour responses to the sequential combination of intravesical therapy with mitomycin-C and BCG-RIVM in multiple superficial bladder tumours. Report from the European Organisation for Research and Treatment on Cancer-Genitourinary Group (EORTC 30897)A P Van der Meijden, R R Hall, M P Macaluso, et al.
Cancer Detection and Prevention|January 1, 1991
Anandron (RU 23908) in metastatic prostate cancer: preliminary results of a multicentric Italian studyF Boccardo, A U Decensi, D Guarneri, et al.
European Urology|January 1, 1977
The treatment of advanced carcinoma of the bladder with a combination of adriamycin and 5-fluorouracilM R Robinson, P H Smith, M P Macaluso, et al.
Anticancer Research|January 19, 1999
Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladderM Alderisio, M Cenci, C Valli, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Urological Research|February 7, 2002
The genetic alterations in the oncogenic pathway of transitional cell carcinoma of the bladder and its prognostic valueP Gontero, A Tizzani, G H Muir, et al.
European Urology|January 1, 1996
Marker tumour responses to the sequential combination of intravesical therapy with mitomycin-C and BCG-RIVM in multiple superficial bladder tumours. Report from the European Organisation for Research and Treatment on Cancer-Genitourinary Group (EORTC 30897)A P Van der Meijden, R R Hall, M P Macaluso, et al.
Cancer Detection and Prevention|January 1, 1991
Anandron (RU 23908) in metastatic prostate cancer: preliminary results of a multicentric Italian studyF Boccardo, A U Decensi, D Guarneri, et al.
European Urology|January 1, 1977
The treatment of advanced carcinoma of the bladder with a combination of adriamycin and 5-fluorouracilM R Robinson, P H Smith, M P Macaluso, et al.
Anticancer Research|January 19, 1999
Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladderM Alderisio, M Cenci, C Valli, et al.
Pageof 1